242 related articles for article (PubMed ID: 31867775)
1. Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
Gonsalves WI; Jevremovic D; Nandakumar B; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Russell S; Lust JA; Lin Y; Go RS; Siddiqui MA; Kyle RA; Gertz MA; Rajkumar SV; Kumar SK
Am J Hematol; 2020 Mar; 95(3):310-315. PubMed ID: 31867775
[TBL] [Abstract][Full Text] [Related]
2. The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
Galieni P; Travaglini F; Vagnoni D; Ruggieri M; Caraffa P; Bigazzi C; Falcioni S; Picardi P; Mazzotta S; Troiani E; Dalsass A; Mestichelli F; Angelini M; Camaioni E; Maravalle D; Angelini S; Pezzoni V
Br J Haematol; 2021 May; 193(3):542-550. PubMed ID: 33792026
[TBL] [Abstract][Full Text] [Related]
3. Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
Du J; Lu J; Gao W; Liu J; He H; Li L; Li R; Zhou L; Jiang H; Chen W; Fu W; Hou J
Ann Hematol; 2020 Aug; 99(8):1779-1791. PubMed ID: 32594218
[TBL] [Abstract][Full Text] [Related]
4. Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.
Gonsalves WI; Rajkumar SV; Gupta V; Morice WG; Timm MM; Singh PP; Dispenzieri A; Buadi FK; Lacy MQ; Kapoor P; Gertz MA; Kumar SK
Leukemia; 2014 Oct; 28(10):2060-5. PubMed ID: 24618735
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myeloma.
Han W; Jin Y; Xu M; Zhao SS; Shi Q; Qu X; Zhang R; Li J; Wu Y; Chen L
Hematology; 2021 Dec; 26(1):510-517. PubMed ID: 34314294
[TBL] [Abstract][Full Text] [Related]
6. Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis.
Li Q; Ai L; Zuo L; Li J; Zhao F; Xu A; Zhang B; Cai L; Hu Y; Sun C
Ann Med; 2024 Dec; 56(1):2338604. PubMed ID: 38599340
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis.
Liu X; Wu F; Ye W; Deng J; Zhang M; Zhang C; Yu Q; Cao L; Gan S; Ma J
BMJ Open; 2024 Jan; 14(1):e071548. PubMed ID: 38216195
[TBL] [Abstract][Full Text] [Related]
8. Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia.
Evans LA; Jevremovic D; Nandakumar B; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Go R; Russell S; Lust JA; Lin Y; Siddiqui M; Kyle RA; Gertz MA; Rajkumar SV; Kumar SK; Gonsalves WI
Am J Hematol; 2020 Jun; 95(6):637-642. PubMed ID: 32129510
[TBL] [Abstract][Full Text] [Related]
9. Quantification of clonal circulating plasma cells in relapsed multiple myeloma.
Gonsalves WI; Morice WG; Rajkumar V; Gupta V; Timm MM; Dispenzieri A; Buadi FK; Lacy MQ; Singh PP; Kapoor P; Gertz MA; Kumar SK
Br J Haematol; 2014 Nov; 167(4):500-5. PubMed ID: 25113422
[TBL] [Abstract][Full Text] [Related]
10. Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression.
Gonsalves WI; Rajkumar SV; Dispenzieri A; Dingli D; Timm MM; Morice WG; Lacy MQ; Buadi FK; Go RS; Leung N; Kapoor P; Hayman SR; Lust JA; Russell SJ; Zeldenrust SR; Hwa L; Kourelis TV; Kyle RA; Gertz MA; Kumar SK
Leukemia; 2017 Jan; 31(1):130-135. PubMed ID: 27457702
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
González-Calle V; Slack A; Keane N; Luft S; Pearce KE; Ketterling RP; Jain T; Chirackal S; Reeder C; Mikhael J; Noel P; Mayo A; Adams RH; Ahmann G; Braggio E; Stewart AK; Bergsagel PL; Van Wier SA; Fonseca R
Ann Hematol; 2018 Aug; 97(8):1453-1462. PubMed ID: 29623394
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients.
Yao W; Yang H; You H; Shang J; Zhai Y; Yan Z; Yan S; Shi X; Yao Y; Wang J; Wang P; Xu Y; Jin S; Yan L; Wu D; Fu C
Front Oncol; 2023; 13():1266868. PubMed ID: 37799469
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C
Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma.
Gonsalves WI; Timm MM; Rajkumar SV; Morice WG; Dispenzieri A; Buadi FK; Lacy MQ; Dingli D; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
Leuk Res; 2016 May; 44():32-9. PubMed ID: 26994849
[TBL] [Abstract][Full Text] [Related]
15. [Application of the Second Revision of the International Staging System (R2-ISS) in the prognostic assessment of newly diagnosed multiple myeloma].
Yan J; Zhou DM; Shao XY; Xu Y; Chen B
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):170-177. PubMed ID: 38604794
[No Abstract] [Full Text] [Related]
16. Prognostic value of circulating plasma cells in patients with multiple myeloma: A meta-analysis.
Li J; Wang N; Tesfaluul N; Gao X; Liu S; Yue B
PLoS One; 2017; 12(7):e0181447. PubMed ID: 28704521
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma.
Ghosh T; Gonsalves WI; Jevremovic D; Dispenzieri A; Dingli D; Timm MM; Morice WG; Kapoor P; Kourelis TV; Lacy MQ; Hayman SR; Buadi FK; Leung N; Go RS; Lin Y; Russell SJ; Lust JA; Zeldenrust SR; Warsame R; Hwa YL; Kyle RA; Gertz MA; Vincent Rajkumar S; Kumar SK
Am J Hematol; 2017 Sep; 92(9):E507-E512. PubMed ID: 28568244
[TBL] [Abstract][Full Text] [Related]
18. Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.
Cowan AJ; Stevenson PA; Libby EN; Becker PS; Coffey DG; Green DJ; Hyun TS; Fromm JR; Gopal AK; Holmberg LA
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1386-1391. PubMed ID: 29481870
[TBL] [Abstract][Full Text] [Related]
19. [Clinical Application of R-ISS Staging System in 412 Newly Diagnosed Patients with Multiple Myeloma].
Chen HM; Wei W; Peng R; Shi HT; Chen XL; Wu LX; Zhou N; Zhou F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):110-114. PubMed ID: 30738456
[TBL] [Abstract][Full Text] [Related]
20. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
Gastinne T; Leleu X; Duhamel A; Moreau AS; Franck G; Andrieux J; Lai JL; Coiteux V; Yakoub-Agha I; Bauters F; Harousseau JL; Zandecki M; Facon T;
Eur J Haematol; 2007 Oct; 79(4):297-304. PubMed ID: 17692103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
